Reply to K.I. Pritchard

MeSH terms

• Antineoplastic Agents, Hormonal / adverse effects
• Antineoplastic Agents, Hormonal / therapeutic use
• Aromatase Inhibitors / adverse effects*
• Aromatase Inhibitors / therapeutic use
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / pathology
• Disease-Free Survival
• Female
• Genital Diseases, Female / chemically induced
• Humans
• Kaplan-Meier Estimate
• Musculoskeletal Diseases / chemically induced
• Outcome Assessment, Health Care / methods
• Outcome Assessment, Health Care / statistics & numerical data
• Proportional Hazards Models
• Tamoxifen / adverse effects*
• Tamoxifen / therapeutic use
• Vasomotor System / drug effects
• Vasomotor System / pathology